Feng Xu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 5%
Papers in
-
- Cancer-related molecular mechanisms research 9
-
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 7
- Inflammasome and immune disorders 4
- Co-authors
- Wenzhou Liu (1 shared paper)Tao Liu (1 shared paper)Hua‐Fu Zhou (1 shared paper)Yu Sun (1 shared paper)Nuo Yang (1 shared paper)Yongsong Chen (8 shared papers)Ling Lin (8 shared papers)Huahao Shen (9 shared papers)
- Journals
- Frontiers in Immunology (4 papers)Aging (4 papers)International Immunopharmacology (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Feng Xu
126 papers receiving 4.7k citations
Feng Xu's Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 633
- Immunology 576
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 748
- Immunology and Allergy 108
Countries citing papers authored by Feng Xu
This map shows the geographic impact of Feng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xu more than expected).
Fields of papers citing papers by Feng Xu
This network shows the impact of papers produced by Feng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xu. The network helps show where Feng Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis Hit paper breakdown → | 2015 | 1475 |
| 2 | 2007 | 177 | |
| 3 | 2015 | 158 | |
| 4 | 2009 | 153 | |
| 5 | 2021 | 147 | |
| 6 | 2012 | 103 | |
| 7 | 2003 | 97 | |
| 8 | 2020 | 87 | |
| 9 | 2009 | 83 | |
| 10 | 2008 | 76 | |
| 11 | 2019 | 71 | |
| 12 | 2008 | 67 | |
| 13 | 2016 | 63 | |
| 14 | 2014 | 62 | |
| 15 | 2008 | 57 | |
| 16 | 2019 | 55 | |
| 17 | 2020 | 53 | |
| 18 | 2008 | 49 | |
| 19 | 2009 | 49 | |
| 20 | 2008 | 49 |
About Feng Xu
Feng Xu is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 131 papers that have together received 4.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (9 papers), Asthma and respiratory diseases (7 papers), Epigenetics and DNA Methylation (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (4 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Cancer Research (633 citations), Immunology (576 citations), Molecular Biology (1.9k citations), Pulmonary and Respiratory Medicine (748 citations) and Immunology and Allergy (108 citations). Feng Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wenzhou Liu, Tao Liu, Hua‐Fu Zhou, Yu Sun, Nuo Yang, Yongsong Chen, Ling Lin, Huahao Shen, Jiexin Chen and Xiaoling Huang. Their work appears in journals such as Frontiers in Immunology, Aging, International Immunopharmacology, Frontiers in Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.